Enovix (NASDAQ:ENVX) Shares Gap Down on Analyst Downgrade

Enovix Corporation (NASDAQ:ENVXGet Free Report) gapped down prior to trading on Thursday after Cantor Fitzgerald lowered their price target on the stock from $30.00 to $25.00. The stock had previously closed at $11.32, but opened at $9.98. Cantor Fitzgerald currently has an overweight rating on the stock. Enovix shares last traded at $8.8030, with a volume of 9,070,872 shares.

Other research analysts also recently issued reports about the company. Benchmark raised their price objective on Enovix from $15.00 to $25.00 and gave the stock a “buy” rating in a report on Friday, July 25th. JPMorgan Chase & Co. restated a “neutral” rating and set a $12.00 price objective (up from $9.00) on shares of Enovix in a report on Thursday, July 24th. Weiss Ratings restated a “sell (d-)” rating on shares of Enovix in a report on Friday, October 31st. Canaccord Genuity Group raised their price objective on Enovix from $20.00 to $22.00 and gave the stock a “buy” rating in a report on Monday, August 4th. Finally, Wall Street Zen downgraded Enovix from a “hold” rating to a “sell” rating in a report on Saturday, September 6th. Five investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $17.25.

Read Our Latest Stock Report on ENVX

Insider Buying and Selling at Enovix

In other news, COO Ajay Marathe sold 18,614 shares of the firm’s stock in a transaction on Wednesday, October 8th. The stock was sold at an average price of $13.00, for a total value of $241,982.00. Following the completion of the sale, the chief operating officer owned 1,002,684 shares of the company’s stock, valued at $13,034,892. This trade represents a 1.82% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 14.10% of the stock is owned by insiders.

Institutional Trading of Enovix

Institutional investors have recently made changes to their positions in the business. Kingstone Capital Partners Texas LLC acquired a new position in Enovix during the 2nd quarter valued at approximately $13,206,000. Electron Capital Partners LLC increased its stake in Enovix by 18.6% during the 1st quarter. Electron Capital Partners LLC now owns 6,712,763 shares of the company’s stock valued at $49,272,000 after purchasing an additional 1,054,029 shares in the last quarter. CenterBook Partners LP increased its stake in Enovix by 71.0% during the 1st quarter. CenterBook Partners LP now owns 1,736,570 shares of the company’s stock valued at $12,746,000 after purchasing an additional 721,309 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Enovix by 65.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,137,777 shares of the company’s stock valued at $8,351,000 after purchasing an additional 449,934 shares in the last quarter. Finally, Nuveen LLC acquired a new stake in Enovix during the 1st quarter worth about $3,030,000. Institutional investors and hedge funds own 50.92% of the company’s stock.

Enovix Trading Down 23.2%

The stock has a 50-day simple moving average of $10.82 and a 200 day simple moving average of $10.18. The company has a current ratio of 4.37, a quick ratio of 4.11 and a debt-to-equity ratio of 0.82. The company has a market cap of $1.71 billion, a price-to-earnings ratio of -10.39 and a beta of 2.09.

Enovix (NASDAQ:ENVXGet Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The company reported ($0.13) EPS for the quarter. Enovix had a negative return on equity of 73.88% and a negative net margin of 481.35%.The firm had revenue of $7.47 million for the quarter. As a group, equities research analysts predict that Enovix Corporation will post -1.01 EPS for the current fiscal year.

About Enovix

(Get Free Report)

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Articles

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.